| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020351 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 01/27/2011 | US20110020350 Contraceptives Based on SP22 and SP22 Antibodies |
| 01/27/2011 | US20110020349 Anti-factor xi monoclonal antibodies and methods of use thereof |
| 01/27/2011 | US20110020348 Pharmaceutical compositions and methods using secreted frizzled related protein |
| 01/27/2011 | US20110020347 Anti-brak (cxcl14) human monoclonal antibody and use thereof |
| 01/27/2011 | US20110020346 Anti-vegf antibodies |
| 01/27/2011 | US20110020345 Drug fusions and conjugates |
| 01/27/2011 | US20110020344 Human monoclonal antibodies specific for cd22 |
| 01/27/2011 | US20110020341 Novel multidrug resistance-associated polypeptide |
| 01/27/2011 | US20110020335 Treatment of Cancers Expressing p95 ErbB2 |
| 01/27/2011 | US20110020332 Prevention of tumors with monoclonal antibodies against neu |
| 01/27/2011 | US20110020331 N-glycosylated antibody |
| 01/27/2011 | US20110020330 Antibody inhibitors of gdf-8 and uses thereof |
| 01/27/2011 | US20110020329 Conjugates of anti-rg-1 antibodies |
| 01/27/2011 | US20110020327 Purification of proteins |
| 01/27/2011 | US20110020323 Gram-positive bacteria specific binding compounds |
| 01/27/2011 | US20110020322 Crystallization of anti-cd20 antibodies |
| 01/27/2011 | US20110020321 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/27/2011 | US20110020295 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 01/27/2011 | US20110020273 Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof |
| 01/27/2011 | US20110020267 Tweak receptor |
| 01/27/2011 | US20110020237 Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders |
| 01/27/2011 | US20110020222 Modified antibodies and methods of use |
| 01/27/2011 | US20110020220 Humanized antibodies against the beta-amyloid peptide |
| 01/27/2011 | US20110020219 Anti-human tenascin monoclonal antibody |
| 01/27/2011 | US20110020218 Novel anti cxcr4 antibodies and their use for the treatment of cancer |
| 01/27/2011 | CA2768658A1 Methods for generating radioimmunoconjugates |
| 01/27/2011 | CA2768325A1 Optimizing the production of antibodies |
| 01/26/2011 | EP2278024A1 Epitope cluster from NY-ESO-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278023A1 Epitope cluster from Melan-A/MART-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278020A2 Antibody gene transfer and recombinant AAV therefor |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278011A2 Neisseria meningitidis antigens |
| 01/26/2011 | EP2278010A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278009A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278008A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278006A2 Neisserial antigens |
| 01/26/2011 | EP2278003A2 Method for controlling the activity of immunologically functional molecule |
| 01/26/2011 | EP2277997A2 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
| 01/26/2011 | EP2277920A2 Inhibitors of complement activation |
| 01/26/2011 | EP2277919A1 Treatment with anti-ERBB2 antibodies |
| 01/26/2011 | EP2277918A2 Mhc class I and II peptide antigens derived from tumour antigen 5t4 |
| 01/26/2011 | EP2277917A2 B7-H3L cell surface target and a family of antibodies recognizing that target |
| 01/26/2011 | EP2277916A2 Use of antibody to M-CSF |
| 01/26/2011 | EP2277915A1 A purified, virus safe antibody preparation |
| 01/26/2011 | EP2277914A2 Antigen binding domains from fish |
| 01/26/2011 | EP2277913A2 Antigen binding domains from fish |
| 01/26/2011 | EP2277908A2 IL-17A/F heterologous polypeptides, antibodies and therapeutic uses thereof |
| 01/26/2011 | EP2277907A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277906A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277905A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277904A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277903A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277902A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277901A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277893A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277892A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277891A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF |
| 01/26/2011 | EP2277543A1 Therapeutic anti-IL-1R1 monoclonal antibody |
| 01/26/2011 | EP2277542A1 Modified antibodies to prostrate-specific membrane antigen and uses thereof |
| 01/26/2011 | EP2277532A1 Novel composition and methods for the treatment of immune related diseases |
| 01/26/2011 | EP2277049A2 Autoantibodies in the detection and treatment of cancer |
| 01/26/2011 | EP2276779A1 Use of a radioactively labelled molecule specifically binding to ed-b fibronectin in a method of hodgkin lymphoma |
| 01/26/2011 | EP2276776A2 Method and affinity column for purifying proteins |
| 01/26/2011 | EP2276509A2 Detection and tratment of pancreatic, ovarian and other cancers |
| 01/26/2011 | EP1912665B1 Vaccine against feline calicivirus (fcv) comprising a fcv capsid protein or an isolated fcv capsid protein comprising protein sequence seq id no: 13 or protein sequences having at least 95% identity thereto. |
| 01/26/2011 | EP1725261B1 Use of agonists and antagonists of interleukin-33 (il-33) |
| 01/26/2011 | EP1660513B1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | EP1303186B1 Medicinal uses of mu-opioid receptor agonists |
| 01/26/2011 | EP1192180B1 Product from starfish |
| 01/26/2011 | EP0951552B1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/26/2011 | EP0948625B1 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 01/26/2011 | EP0946725B1 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 01/26/2011 | CN101960309A Composition and method for diagnosis or detection of gastric cancer |
| 01/26/2011 | CN101959529A Methods of treating inflammatory pain |
| 01/26/2011 | CN101959528A Methods of treating chronic pain |
| 01/26/2011 | CN101957379A HPPCn antibody, antisense oligonucleotide and application of RNA interference in tumor diagnosis and treatment |
| 01/26/2011 | CN101957377A Method for preparing fluorescent antibody for detecting avian influenza virus and solid phase immunofluorescence detection kit |
| 01/26/2011 | CN101957376A Colloidal gold chromatography test paper for rapidly detecting guanidineacetic acid and derivatives thereof and preparation method thereof |
| 01/26/2011 | CN101955956A Eimeria tenella calcium-dependent protein kinase gene and application thereof |
| 01/26/2011 | CN101955940A Gene sequence of variable regions of anti-vibrio alginolyticus idiotype monoclonal antibody |
| 01/26/2011 | CN101955545A Multi-target recombination gene and application of protein thereof in preventing and treating infection of helicobacter pylori |
| 01/26/2011 | CN101955542A Immunoassay kit and special antibody for detecting fumonisins |
| 01/26/2011 | CN101955541A Clenbuterol detection immunoassay kit and special antibody thereof |
| 01/26/2011 | CN101955540A Antibody against fluoroquinolones and application thereof |
| 01/26/2011 | CN101955539A Immunoassay kit for detecting chloramphenicol and dedicated antibody thereof |
| 01/26/2011 | CN101955538A Anti-streptomycin antibody and application thereof |
| 01/26/2011 | CN101955537A Anti-ractopamine antibody and application thereof |
| 01/26/2011 | CN101955536A Anti-sulfonamides antibody and application thereof |
| 01/26/2011 | CN101955535A Gentamicin antibody and application thereof |
| 01/26/2011 | CN101955534A Anti-trionyx sinensis immune globulin monoclonal antibody and application thereof |
| 01/26/2011 | CN101955533A Light chain and heavy chain variable regions of anti-SEB (Staphylococcal Enterotoxin B) monoclonal antibody FMU-SEB-No.1 with high neutralizing activity |
| 01/26/2011 | CN101955532A Method for extracting chicken egg yolk antibodies against infectious bursal disease |
| 01/26/2011 | CN101955531A Antibody for detecting porcine reproductive and respiratory syndrome virus |
| 01/26/2011 | CN101955530A Process for extracting and purifying crucian IgM |
| 01/26/2011 | CN101955529A Method for extracting yolk immune globulin by one-way ultrafiltration |